Press Releases

Year

Mar 2015

LifeVantage Presenting at Experimental Biology Annual Meeting

Nathalie Chevreau, PhD to Present Findings From Clinical Research on LifeVantage's Canine Health Product

PDF Version

Mar 2015

LifeVantage Launches International Operations in Thailand

SALT LAKE CITY , March 26, 2015 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), has announced the expansion of its its direct selling business into Thailand . The company has opened an office in the city of Bangkok to support this new market.

PDF Version

Mar 2015

LifeVantage Hosts Female Entrepreneur Business Building Event

Sold Out Event Focused on Professional Empowerment for Women in Business

PDF Version

Feb 2015

LifeVantage Multi-dimensional Energy Product AXIO Launches in Japan

Company Expands Its Presence Within the Global Energy Drink Market

PDF Version

Feb 2015

Protandim Earns NSF Product Certification

LifeVantage Corporation Flagship Product, Protandim, Passes Globally Recognized Quality Certification Program

PDF Version

Feb 2015

LifeVantage Announces Second Quarter Fiscal Year 2015 Results

Revenue During First Six Months of Fiscal Year 2015, Excluding Japan, Increased 4.5% Repurchased $4.6 Million Common Stock in Second Quarter Generated $13 Million of Adjusted EBITDA in the First Six Months of Fiscal Year 2015 SALT LAKE CITY , Feb. 4, 2015 (GLOBE NEWSWIRE) -- LifeVantage Corporation

PDF Version

Feb 2015

LifeVantage Corporation Announces Executive Leadership Change

- Independent Director Dave S. Manovich to serve as Executive Vice Chairman - - Board forms search committee for new CEO - SALT LAKE CITY , Feb. 2, 2015 (GLOBE NEWSWIRE) -- LifeVantage Corporation ("LifeVantage" or the "Company") (Nasdaq:LFVN) announced today the appointment of Dave S.

PDF Version

Jan 2015

LifeVantage to Announce Second Quarter Fiscal Year 2015 Results on February 4, 2015

SALT LAKE CITY , Jan. 20, 2015 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its second quarter ended December 31, 2014 , after the market closes on Wednesday, February 4, 2015 . The Company will hold an investor conference call

PDF Version

Jan 2015

LifeVantage CSO Presenting at Biochemical Society Keap1/Nrf2 Pathway in Health and Disease Meeting

Shawn M. Talbott, PhD Presenting Regarding Phytonutrient Activation of the Nrf2 Pathway

PDF Version

Dec 2014

LifeVantage Opens Corporate Office in Hong Kong

New Office Space Will Support Growth Within the Hong Kong Region

PDF Version

Pagination

First page
Previous page
…
Page 23
Page 24
Page 25
Page 26
Current page 27
Page 28
Page 29
Page 30
Page 31
…
Next page
Last page